{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:06:38Z","timestamp":1790334398265,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,29]],"date-time":"2014-11-29T00:00:00Z","timestamp":1417219200000},"content-version":"vor","delay-in-days":697,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1111\/1469-0691.12029","type":"journal-article","created":{"date-parts":[[2012,9,24]],"date-time":"2012-09-24T00:13:09Z","timestamp":1348445589000},"page":"23-28","source":"Crossref","is-referenced-by-count":13,"title":["Applying proteomic technology to clinical virology"],"prefix":"10.1016","volume":"19","author":[{"given":"C.","family":"Mancone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ciccosanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Montaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Perdomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Piacentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Alonzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.M.","family":"Fimia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tripodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1469-0691.12029_bib1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.mib.2009.06.003","article-title":"Virus\u2013host interactions: from systems biology to translational research","volume":"12","author":"Peng","year":"2009","journal-title":"Curr Opin Microbiol"},{"key":"10.1111\/1469-0691.12029_bib2","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nrmicro1890","article-title":"Modification of intracellular membrane structures for virus replication","volume":"6","author":"Miller","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1111\/1469-0691.12029_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1074\/mcp.M100015-MCP200","article-title":"2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers","volume":"1","author":"Zhou","year":"2002","journal-title":"Mol Cell Proteomics"},{"key":"10.1111\/1469-0691.12029_bib4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1083\/jcb.201004052","article-title":"Mass spectrometry-based proteomics in cell biology","volume":"190","author":"Walther","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1111\/1469-0691.12029_bib5","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nature01511","article-title":"Mass spectrometry-based proteomics","volume":"422","author":"Aebersold","year":"2003","journal-title":"Nature"},{"key":"10.1111\/1469-0691.12029_bib6","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nchembio736","article-title":"Mass spectrometry-based proteomics turns quantitative","volume":"1","author":"Ong","year":"2005","journal-title":"Nat Chem Biol"},{"key":"10.1111\/1469-0691.12029_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-5956-7-8","article-title":"Biomarkers of HIV-1 associated dementia: proteomic investigation of sera","volume":"7","author":"Wiederin","year":"2009","journal-title":"Proteome Sci"},{"key":"10.1111\/1469-0691.12029_bib8","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s00284-010-9608-3","article-title":"iTRAQ-coupled 2D LC-MS\/MS analysis of secreted proteome of HBV-replicating HepG2 cells: potential in biomarkers for prognosis of HCC","volume":"61","author":"Feng","year":"2010","journal-title":"Curr Microbiol"},{"key":"10.1111\/1469-0691.12029_bib9","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1074\/mcp.M900345-MCP200","article-title":"Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes in Vero cells infected with the coronavirus infectious bronchitis virus","volume":"9","author":"Emmott","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"10.1111\/1469-0691.12029_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.aca.2011.06.045","article-title":"Mass spectrometry based proteomic studies on viruses and hosts\u2019a review","volume":"702","author":"Zheng","year":"2011","journal-title":"Anal Chim Acta"},{"key":"10.1111\/1469-0691.12029_bib11","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1073\/pnas.0700760104","article-title":"Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins","volume":"104","author":"Huang","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/1469-0691.12029_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1056\/NEJM200107053450107","article-title":"Hepatitis C virus infection","volume":"345","author":"Lauer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1111\/1469-0691.12029_bib13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MOG.0b013e3283528e1e","article-title":"Hepatitis C therapy update","volume":"28","author":"Casey","year":"2012","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1111\/1469-0691.12029_bib14","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1053\/j.gastro.2012.02.013","article-title":"Maximizing opportunities and avoiding mistakes in triple therapy for hepatitis C virus","volume":"142","author":"Barritt","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1111\/1469-0691.12029_bib15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1136\/gut.2010.211292","article-title":"Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins","volume":"60","author":"Mancone","year":"2011","journal-title":"Gut"},{"key":"10.1111\/1469-0691.12029_bib16","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.1021\/pr201128s","article-title":"Ferritin heavy chain is the host factor responsible for HCV-induced inhibition of apoB-100 production and is required for efficient viral infection","volume":"11","author":"Mancone","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1111\/1469-0691.12029_bib17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/hep.21751","article-title":"Proteomic profiling of human liver biopsies: hepatitis C virus-induced fibrosis and mitochondrial dysfunction","volume":"46","author":"Diamond","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/1469-0691.12029_bib18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hep.25649","article-title":"Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease post-transplantation","volume":"56","author":"Diamond","year":"2012","journal-title":"Hepatology"},{"key":"10.1111\/1469-0691.12029_bib19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1111\/1469-0691.12029_bib20","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1053\/j.gastro.2005.01.059","article-title":"Hepatic gene expression discriminates responders and non-responders in treatment of chronic hepatitis C viral infection","volume":"128","author":"Chen","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1111\/1469-0691.12029_bib21","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1021\/pr2006445","article-title":"Liver protein profiling in chronic hepatitis C: identification of potential predictive markers for interferon therapy outcome","volume":"11","author":"Perdomo","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1111\/1469-0691.12029_bib22","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1021\/pr100923u","article-title":"Protein pathway activation associated with sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon (PEG-IFN) and ribavirin (RBV)","volume":"10","author":"Younossi","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1111\/1469-0691.12029_bib23","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1053\/j.gastro.2006.02.059","article-title":"Serum proteome to predict virologic response in patients with hepatitis C treated by pegylated interferon plus ribavirin","volume":"130","author":"Paradis","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1111\/1469-0691.12029_bib24","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.24284","article-title":"High predictive accuracy of an unbiased proteomic profile for sustained virologic response in chronic hepatitis C patients","volume":"53","author":"Patel","year":"2011","journal-title":"Hepatology"},{"key":"10.1111\/1469-0691.12029_bib25","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1021\/pr101077c","article-title":"New approaches for biomarker discovery: the search for liver fibrosis markers in hepatitis C patients","volume":"10","author":"Gangadharan","year":"2011","journal-title":"J Proteome Res"},{"key":"10.1111\/1469-0691.12029_bib26","doi-asserted-by":"crossref","first-page":"e39603","DOI":"10.1371\/journal.pone.0039603","article-title":"Discovery of novel biomarker candidates for liver fibrosis in hepatitis C patients: a preliminary study","volume":"7","author":"Gangadharan","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1111\/1469-0691.12029_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/hep.24703","article-title":"Identification osteopontin as a novel marker for early hepatocellular carcinoma","volume":"55","author":"Shang","year":"2012","journal-title":"Hepatology"},{"key":"10.1111\/1469-0691.12029_bib28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.bbrc.2012.04.099","article-title":"Serum anti-Ku86 is a potential biomarker for early detection of hepatitis C virus-related hepatocellular carcinoma","volume":"421","author":"Nomura","year":"2012","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14603050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14603050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T10:27:10Z","timestamp":1542709630000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14603050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S1198743X14603050"],"URL":"https:\/\/doi.org\/10.1111\/1469-0691.12029","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}